COMMUNIQUÉS West-GlobeNewswire

Is pot bad for your heart? Truth is… we don’t know yet
20/06/2018
OTTAWA, June 20, 2018 (GLOBE NEWSWIRE) -- As the Canadian Senate officially passes Bill C-45 on Marijuana legalization, the University of Ottawa Heart Institute (UOHI) has looked at the effects of marijuana on the heart [...]
Le pot, inoffensif pour le cœur? Pas si vite…
20/06/2018
OTTAWA, 20 juin 2018 (GLOBE NEWSWIRE) -- Le Sénat du Canada vient d’adopter le projet de loi C-45, portant sur la légalisation de la marijuana. L’Institut de cardiologie de l’Université d’Ottawa en profite pour se [...]
Medtronic Announces Second Bone Cement Solution Indicated for Treating Sacral Fractures
20/06/2018
Delivering Commitment to Find New Treatment Options for Patients Suffering from Sacral Insufficiency Fractures DUBLIN - June 20, 2018- Medtronic plc (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA [...]
Easton Pharmaceuticals Announces New Director / Officer to Its Board and Updates to Business Direction
20/06/2018
TORONTO, ON, June 20, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals Inc. (OTC: EAPH ) is pleased to announce a new director and officer to its board with the appointment of Mr. Vince Demasi of Alliance Group, as Chief [...]
Teligent, Inc. Announces FDA Approval of Fluocinonide Gel, 0.05%
20/06/2018
BUENA, N.J., June 20, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]
Keryx Biopharmaceuticals Announces Participation in a Renal Disease Panel at the JMP Securities Life Sciences Conference on Thursday, June 21st
20/06/2018
BOSTON, June 20, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced participating [...]
Paratek Announces FDA Advisory Committee Date for Omadacycline
20/06/2018
BOSTON, June 20, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]
NewLink Genetics Announces Updated Data for Indoximod Plus Radio-Immunotherapy in DIPG to be Presented at ISPNO 2018 Meeting
20/06/2018
AMES, Iowa, June 20, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that updated data for patients with diffuse intrinsic pontine glioma (DIPG) from NLG2105 , a Phase 1 study [...]
Agritek Holdings, Inc. Applauds Move By Canada That Just Legalized Marijuana Bringing Big Implications And Paving Way For New US Drug Policy
20/06/2018
Canada Now the Second Country in the World to Legalize Cannabis, Following Uruguay LOS ANGELES, CA, June 20, 2018 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, [...]
Zosano Announces Publication on Adhesive Dermally-Applied Microarray (ADAM™) Technology for the Delivery of Zolmitriptan in Migraine in Journal of Pharmaceutics
20/06/2018
Peer reviewed article evaluates effect of skin models on in vitro performance of ADAM FREMONT, Calif., June 20, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”), a clinical- [...]
Alder BioPharmaceuticals® to Present New Data Further Highlighting Eptinezumab’s Efficacy Profile for Migraine Prevention at American Headache Society Meeting
20/06/2018
New eptinezumab data at two late-breaking sessions demonstrate efficacy that is sustained and further improved after repeat treatments BOTHELL, Wash., June 20, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. ( [...]
Emblem to Launch Emblem Germany in Joint Venture with Acnos Pharma
20/06/2018
TORONTO, June 20, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (TSXV:EMC.WT) (OTCBB:EMMBF) (“Emblem” or the “Company”), is pleased to announce that its Board of Directors has approved the Company’s formation of a [...]
PositiveID CEO Details New Distribution Agreement with Leading Non-Invasive Patient Monitoring Technology Company
20/06/2018
Agreement for new Bluetooth thermometer and other topics discussed in interview with CEOLIVE.TV DELRAY BEACH, Fla., June 20, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (the “Company”) (OTC:PSID), a life sciences [...]
HealthEC Announces Beaumont Health as New Client for Population Health Management Solution
20/06/2018
Beaumont Cites Breadth of HealthEC’s Data Aggregation and Analytics Capabilities as Key Reasons for Joining Platform PISCATAWAY, N.J., June 20, 2018 (GLOBE NEWSWIRE) -- HealthEC , which earned the highest overall vendor [...]
WishBone Medical, Inc. announces Randal R. Betz, M.D. as Chief Medical Officer
20/06/2018
WARSAW, Ind., June 20, 2018 (GLOBE NEWSWIRE) -- WishBone Medical, Inc. is pleased to announce the appointment of Randal R. Betz, M.D. as Chief Medical Officer. Dr. Betz, on a part time consulting basis, will provide [...]
OncBioMune to Commence Phase 2 Trial of ProscaVax for Early Stage Prostate Cancer Patients
20/06/2018
BATON ROUGE, La., June 20, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]
Samumed Presents Clinical and Preclinical Data at European League Against Rheumatism (EULAR) 2018 Annual Congress
20/06/2018
Phase 2 data in osteoarthritis and preclinical data in tendinopathy and psoriasis demonstrated the emerging breadth of the Samumed pipeline in arthritis related diseases and in dermatology SAN DIEGO, June 20, 2018 ( [...]
Cianna Medical Showcased the SAVI SCOUT® Radar Breast Localization System at Premier Inc.’s Annual Breakthroughs Conference
20/06/2018
ALISO VIEJO, Calif., June 20, 2018 (GLOBE NEWSWIRE) -- Cianna Medical’s SAVI SCOUT ® Radar Breast Localization System is one of the medical innovations that was showcased in front of thousands of healthcare providers at [...]
Moleculin Receives Approval for Leukemia Clinical Trial
20/06/2018
HOUSTON, June 20, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq:MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]

Pages